Literature DB >> 11431060

Sertraline versus small doses of haloperidol in the treatment of agitated behavior in patients with dementia.

S Gaber1, S Ronzoli, A Bruno, A Biagi.   

Abstract

Entities:  

Year:  2001        PMID： 11431060     DOI： 10.1016/s0167-4943(01)00135-2

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr Suppl        ISSN： 0924-7947


× No keyword cloud information.
  8 in total

1.  Gabapentin and pregabalin to treat aggressivity in dementia: a systematic review and illustrative case report.

Authors:  Thitiporn Supasitthumrong; Blanca M Bolea-Alamanac; Selim Asmer; Vincent L Woo; Petal S Abdool; Simon J C Davies
Journal:  Br J Clin Pharmacol       Date:  2019-02-08       Impact factor: 4.335

Review 2.  Update on SSRI Treatment for Neuropsychiatric Symptoms of Dementia.

Authors:  James M Wilkins; Brent P Forester
Journal:  Curr Psychiatry Rep       Date:  2016-02       Impact factor: 5.285

3.  Behavioral and psychological symptoms of dementia and their management.

Authors:  Nilamadhab Kar
Journal:  Indian J Psychiatry       Date:  2009-01       Impact factor: 1.759

4.  Pharmacological treatments for alleviating agitation in dementia: a systematic review and network meta-analysis.

Authors:  Khachen Kongpakwattana; Ratree Sawangjit; Itthipol Tawankanjanachot; J Simon Bell; Sarah N Hilmer; Nathorn Chaiyakunapruk
Journal:  Br J Clin Pharmacol       Date:  2018-05-14       Impact factor: 4.335

5.  Pharmacologic management of behavioral and psychological symptoms of major neurocognitive disorder.

Authors:  Monica Mathys
Journal:  Ment Health Clin       Date:  2018-11-01

Review 6.  Pharmacological treatments for neuropsychiatric symptoms of dementia in long-term care: a systematic review.

Authors:  Dallas P Seitz; Sudeep S Gill; Nathan Herrmann; Sarah Brisbin; Mark J Rapoport; Jenna Rines; Kimberley Wilson; Ken Le Clair; David K Conn
Journal:  Int Psychogeriatr       Date:  2012-10-19       Impact factor: 3.878

7.  Sequential drug treatment algorithm for agitation and aggression in Alzheimer's and mixed dementia.

Authors:  Simon Jc Davies; Amer M Burhan; Donna Kim; Philip Gerretsen; Ariel Graff-Guerrero; Vincent L Woo; Sanjeev Kumar; Sarah Colman; Bruce G Pollock; Benoit H Mulsant; Tarek K Rajji
Journal:  J Psychopharmacol       Date:  2018-01-17       Impact factor: 4.153

8.  Antipsychotic discontinuation after the initiation of selective serotonin reuptake inhibitors therapy for the treatment of behavioral and psychological symptoms associated with dementia.

Authors:  Monica Mathys; Steven Fang; Jini John; Jasmine Carter
Journal:  Ment Health Clin       Date:  2018-04-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.